NANOVIRICIDES, INC.
Income Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | $6.6M | $5.0M | $3.7M | $5.1M | $4.3M | $4.3M | $4.2M | $3.4M |
| SG&A Expense | $3.0M | $3.8M | $3.4M | $3.5M | $2.3M | $1.8M | $2.3M | $1.7M |
| Operating Income | $-9.6M | $-8.9M | $-7.1M | $-8.7M | $-6.6M | $-6.1M | $-6.4M | $-4.9M |
| Operating Margin | — | — | — | — | — | — | — | — |
| Interest Expense | $780.8K | $1.0M | $2.6M | $3.1M | $962.5K | $0 | $0 | — |
| Pretax Income | $-10.3M | $-10.7M | $-2.2M | $-13.6M | $-8.9M | $-6.2M | $-6.5M | $-4.7M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | $-10.3M | $-10.7M | $-2.2M | $-13.6M | $-8.9M | $-6.2M | $-6.5M | $-4.7M |
| Net Margin | — | — | — | — | — | — | — | — |
| EPS (Basic) | $-0.17 | $-0.19 | $-0.04 | $-0.27 | $-0.19 | $-0.15 | $-0.16 | $-0.04 |
| EPS (Diluted) | $-0.17 | $-0.19 | $-0.09 | $-0.27 | $-0.19 | $-0.15 | $-0.16 | $-0.04 |
| Shares Outstanding (Basic) | 60.1M | 57.7M | 56.6M | 51.2M | 45.9M | 155.6M | 143.5M | — |
| Shares Outstanding (Diluted) | 60.1M | 57.7M | 59.2M | 51.2M | 47.6M | 155.6M | 143.5M | — |
| Dividends Per Share | — | — | — | — | — | — | — | — |